The fastest way to end a gout flare is to take an anti-inflammatory medication as soon as symptoms begin, ideally within the first hours. The three proven options for acute attacks are NSAIDs, low-dose colchicine, and corticosteroids, and trials show all three produce roughly equivalent pain relief. Which one you use matters less than how quickly you start it, and the rest of the picture, from diet changes to long-term uric acid management, fills in around that core principle.
The Three First-Line Medications
Gout flares are driven by an intense inflammatory response to urate crystals in a joint, and the drugs that work fastest all target that inflammation rather than the crystals themselves. Current treatment guidelines recommend NSAIDs, colchicine, or corticosteroids as first-line options, and in some cases a combination of two agents.1PubMed Central. Gouty Arthritis: A Review of Acute Management and Prevention Each works through a different mechanism, but they arrive at roughly the same destination: meaningful pain reduction within a day or two.
NSAIDs like naproxen and indomethacin are the most commonly used option because they are widely available, including over the counter in many countries. A randomized trial comparing naproxen to oral prednisolone (a corticosteroid) found that both reduced pain by about 45 mm on a 100-point scale after 90 hours, with no meaningful difference between them.2The Lancet. Oral prednisolone and naproxen in the treatment of monoarticular gout A separate multicenter trial comparing indomethacin with prednisolone found the same pattern: both produced clinically significant pain reduction at rest and during activity from day one through day fourteen.3PubMed. Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial
Colchicine works differently from NSAIDs and steroids. It interferes with the inflammatory cells that swarm to the crystal deposits. Low-dose colchicine, taken as early as possible at a total dose of about 1.8 mg spread over one hour, reduces pain effectively while being well tolerated.4PubMed. Colchicine for the treatment of gout The old advice to take colchicine every hour until you got diarrhea has been abandoned because that high-dose approach caused severe gastrointestinal side effects without any extra benefit. The low-dose regimen works just as well with far fewer problems.
Corticosteroids, whether oral prednisolone or an injection directly into the swollen joint, are the go-to when NSAIDs are off the table, such as for people with kidney problems, stomach ulcers, or those on blood thinners. The trial data described above confirms they perform on par with NSAIDs.
Why Getting the Timing Right Matters Most
Across all three drug classes, the single biggest factor determining how fast you get relief is how early you take the first dose. The concept sometimes called “pills in the pocket” means keeping your medication on hand so you can take it the moment you feel that telltale warmth, stiffness, or swelling starting in a joint. Waiting twelve or twenty-four hours while hoping it will pass on its own gives the inflammatory cascade time to build momentum, and once that cascade is fully ramped up, it takes longer for any drug to rein it in.
Untreated gout flares are self-limiting. The body eventually switches on its own anti-inflammatory machinery, including factors like TGF-β1 and IL-10, and pain typically resolves within seven to ten days even without medication.5RMD Open. Spontaneous resolution of acute gout: mechanisms and therapeutic targets But seven to ten days of excruciating joint pain is a long time to wait when treatment can cut that down substantially. The urate crystals themselves trigger a specific pathway involving the NLRP3 inflammasome, which pumps out the inflammatory signaling molecule IL-1β.6PubMed Central. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout Early treatment interrupts this chain before it reaches full intensity.
When Standard Treatments Are Not an Option
Some people cannot tolerate any of the big three. Kidney disease rules out most NSAIDs and requires careful colchicine dosing. Diabetes or infections can make corticosteroids risky. For these patients, a newer class of drugs that directly block IL-1β, the key inflammatory signal in gout, has emerged as an alternative. A systematic review and meta-analysis found that IL-1 inhibitors produce significant and clinically meaningful pain reduction in acute flares, with canakinumab showing the strongest effect and anakinra performing comparably to standard treatments.7Archives of Clinical Rheumatology. Interleukin-1 Inhibitors for Acute Gout Flares: A Systematic Review and Meta-analysis A separate systematic review reached a similar conclusion: IL-1β inhibitors appear beneficial and safe for people whose gout flares cannot be managed with conventional drugs.8PubMed Central. Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
An early pilot study gave anakinra to ten patients who had failed or could not tolerate standard therapies. All ten responded rapidly, with no adverse effects.9PubMed Central. A pilot study of IL-1 inhibition by anakinra in acute gout These drugs are not first-line because they are expensive, require a prescription from a specialist, and the evidence base is still smaller than what exists for NSAIDs or colchicine. But if you have been told that your kidneys or stomach cannot handle the usual options, they are worth asking about.
Non-Drug Measures That Help During a Flare
While you wait for medication to kick in, a few practical steps make a difference. Elevating the affected joint reduces swelling. Applying ice wrapped in a cloth for fifteen to twenty minutes at a time can numb some of the pain and tamp down local inflammation. Stay well hydrated, because dehydration concentrates uric acid in the blood and can worsen crystal formation.
What you eat and drink during a flare matters too, though dietary changes alone will not end an acute attack. Alcohol, especially beer, red meat, organ meats, shellfish, and drinks sweetened with high-fructose corn syrup are all established triggers for flares and elevated uric acid.10PubMed Central. Environmental Triggers of Hyperuricemia and Gout Cutting these out during a flare removes fuel from the fire, even if it does not extinguish it.
Dairy products, interestingly, appear to be protective. A large prospective study found that men with the highest dairy intake had roughly half the risk of developing gout compared to those who consumed the least dairy. The same study found that purine-rich vegetables, often feared by gout patients, were not associated with increased gout risk.11New England Journal of Medicine. Purine-rich foods, dairy and protein intake, and the risk of gout in men So skipping the spinach salad out of gout anxiety is unnecessary, while adding yogurt or milk to your diet may actually help.
Do Cherries Actually Work?
Cherry juice and cherry extract supplements are among the most popular natural remedies for gout, and there is some legitimate science behind the folklore. A systematic review found a positive correlation between tart cherry juice consumption and reduced uric acid levels, though the effects were modest and the studies were small.12PubMed Central. Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review One study of tart cherry concentrate reported that uric acid in the blood dropped by about 36% at eight hours after a dose, while uric acid excretion through the kidneys spiked, suggesting the cherries were helping the body clear urate faster.13Journal of Functional Foods. Montmorency tart cherry (Prunus cerasus L.) concentrate lowers uric acid, independent of plasma cyanidin-3-O-glucosiderutinoside
That said, cherries are not a replacement for medication during an acute flare. The urate-lowering effect is temporary and small compared to what drugs achieve. Think of cherry juice as a reasonable complementary measure, something that probably helps a little and is unlikely to cause harm, rather than a treatment plan on its own.
Should You Start Urate-Lowering Therapy During a Flare?
There is a long-standing belief, still held by many doctors, that starting a uric acid-lowering drug like allopurinol during an active flare will make the attack worse. The logic sounds reasonable: changing uric acid levels rapidly can trigger crystal shedding, which could intensify inflammation. But the clinical evidence does not support this concern. A randomized trial found no significant difference in days to resolution when patients started allopurinol during a flare compared to placebo.14PubMed. Does starting allopurinol prolong acute treated gout? A randomized clinical trial A second randomized trial comparing early versus late allopurinol initiation during a flare found the same thing: median time to complete resolution was about six days in both groups.15PubMed. Early versus Late Allopurinol Initiation in Acute Gout Flare (ELAG): a randomized controlled trial
This means there is no need to delay starting allopurinol if you and your doctor have already decided it is time. Delaying wastes weeks during which uric acid levels remain high and new crystal deposits can form. The preferred approach is “start low, go slow,” beginning at a low dose and gradually increasing it. However, that gradual introduction does not eliminate flare risk entirely. A trial testing whether colchicine prophylaxis could be skipped during the start-low-go-slow phase found that patients on placebo had roughly twice as many flares per month as those on low-dose colchicine, and the study could not establish that going without prophylaxis was equivalent.16Annals of the Rheumatic Diseases. Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial So low-dose colchicine alongside allopurinol during the first several months remains a smart strategy.
Prophylaxis may be especially important for people who had a flare in the month before starting allopurinol and who are beginning at the standard 100 mg daily starting dose.17PubMed. Predicting Gout Flares in People Starting Allopurinol Using the Start-Low Go-Slow Dose Escalation Strategy
What Happens When Nothing Else Works
A small percentage of gout patients have what is called refractory gout. They either cannot tolerate allopurinol or febuxostat, or those drugs fail to bring uric acid below target despite adequate dosing. These patients often develop tophi, which are visible lumps of crystallized urate under the skin, and suffer frequent, debilitating flares.
Pegloticase is a biologic drug designed specifically for this group. Unlike allopurinol, which blocks the enzyme that produces uric acid, pegloticase is a recombinant uricase enzyme that actually breaks down urate already circulating in the blood.18PubMed. Pegloticase treatment of chronic refractory gout: Update on efficacy and safety Given as an intravenous infusion every two weeks, it drops uric acid levels dramatically. In patients who responded to the drug, long-term follow-up showed sustained uric acid levels below the target threshold, progressive resolution of tophi, and fewer flares over time. Complete tophus resolution occurred in about 87% of those who maintained a response.19Annals of the Rheumatic Diseases. Long-term safety of pegloticase in chronic gout refractory to conventional treatment
The catch is that a significant proportion of patients develop antibodies against pegloticase, which neutralize it and cause the response to fail. Newer protocols that pair pegloticase with immunosuppressive drugs to prevent antibody formation are showing promising results, but this is a specialized treatment available only through rheumatologists, not something you would use for a typical flare.
Making Sure It Is Actually Gout
Speed matters, but speed aimed at the wrong diagnosis can be dangerous. Gout and septic arthritis, a bacterial joint infection, look strikingly similar: both cause a hot, red, swollen, excruciatingly painful joint. Septic arthritis is a medical emergency requiring drainage and intravenous antibiotics, and treating it with colchicine while the infection spreads could lead to permanent joint damage or worse.20PubMed. Analysis of synovial inflammatory markers to differ infectious from gouty arthritis
The gold standard for confirming gout is drawing fluid from the joint with a needle and examining it under a polarizing microscope for urate crystals. But that is not always possible. Some joints are hard to access, and some flares produce too little fluid to aspirate. Dual-energy CT scanning has become an increasingly useful backup. It can identify urate crystal deposits non-invasively, including in tendons and other soft tissues outside the joint itself where a needle aspiration might miss them.21PubMed Central. Dual‐energy CT in gout – A review of current concepts and applications One study found that roughly 30% of patients whose joint fluid analysis came back negative for crystals were correctly identified as having gout by dual-energy CT, often because their crystal deposits sat around tendons rather than inside the joint space.22Annals of the Rheumatic Diseases. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study
If this is your first episode and you have not had a confirmed diagnosis before, resist the urge to self-treat with leftover medication and see a doctor. The overlap between gout and infection is too large to gamble on.23PubMed Central. Clinical significance of delta neutrophil index in the differential diagnosis between septic arthritis and acute gout attack within 24 hours after hospitalization
Colchicine and Kidney Disease
Kidney disease and gout travel together frequently. Impaired kidneys clear uric acid poorly, which raises blood levels and promotes crystal formation. But kidney disease also complicates treatment, because colchicine is partially cleared through the kidneys and can accumulate to toxic levels if the dose is not adjusted. For a long time, many clinicians simply avoided colchicine in anyone with significantly reduced kidney function.
More recent data suggests that very low doses can be used safely under close supervision. A study of 54 patients with severe chronic kidney disease who were given colchicine for crystal-induced arthritis flares found that when doses were kept at 0.5 mg per day or lower, the drug was well tolerated in about 77% of cases, effective in about 83%, and no serious adverse events were recorded.24RMD Open. Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease This does not mean you should adjust your own dose. It does mean that if a doctor has told you colchicine is completely off the table because of your kidneys, it may be worth revisiting that conversation with a rheumatologist familiar with the newer evidence.
Why Humans Are Especially Prone to Gout
Most mammals never get gout because they have a working enzyme called uricase that breaks uric acid down into a much more soluble compound easily flushed by the kidneys. Humans, along with other great apes, lost this enzyme millions of years ago through multiple independent genetic mutations that disabled the uricase gene.25PubMed Central. Evolutionary history and metabolic insights of ancient mammalian uricases The result is that our baseline uric acid levels are several times higher than those of most other mammals, putting us perpetually close to the crystallization threshold.
Why natural selection would tolerate this is still debated. One hypothesis is that uric acid acts as a potent antioxidant in the blood, and higher levels may have conferred survival advantages in early primates living on fruit-heavy, vitamin C-poor diets. Another is that elevated uric acid helped maintain blood pressure during periods of fasting or salt scarcity. Whatever the reason, the practical consequence is that humans sit on a biochemical knife edge. Even modest increases in uric acid from diet, dehydration, medications, or kidney slowdowns can push concentrations past the point where crystals form. That is also why pegloticase, the drug reserved for refractory gout, works by essentially replacing the uricase enzyme that evolution took away from us.